MentalHealthDaily

Pharmacogenomics (PGx) for Depression: Genetic Analysis to Amplify Antidepressant Efficacy? (2023 Review)

by GLOOM

Depression, a leading cause of disability globally, often presents challenges in treatment due to the variability in individual responses to antidepressants. Pharmacogenomic (PGx) testing, an approach aligning treatment with genetic makeup, promises to tailor depression therapy more effectively. Highlights: Major Depressive Disorder (MDD) impacts a significant portion of the global population, with traditional treatments often …

Genetics of Major Depression vs. Symptom Scales (PHQ-9 & CIDI-SF) (2023 Study)

by GLOOM

Major Depressive Disorder (MDD) presents a significant challenge in mental health, with its complex genetic and symptomatic landscape. Recent research focusing on the UK Biobank data has compared the genetic underpinnings of MDD symptoms assessed by the PHQ-9 and CIDI-SF tools. This comparison has highlighted significant differences in their genetic correlations and implications for understanding …

Intranasal CRISPR Gene Editing for Anxiety via HTR2A Gene (5-HT2A Receptors) in Mice (2023 Study)

by GLOOM

The innovative use of CRISPR/Cas9 gene-editing technology has taken a leap forward in mental health treatment. A new study has demonstrated the successful noninvasive intranasal delivery of this technology to modify neural circuits in the central nervous system, targeting the HTR2A gene associated with anxiety and depression. This breakthrough offers a glimpse into the future …

Brain Gene Editing with CRISPR-Cas9 RNPs as Non-Viral Vector Alternative in Mice (2023 Study)

by GLOOM

CRISPR-Cas9 technology, a powerful tool for gene editing, has made significant strides in therapeutic applications, especially within the central nervous system (CNS). A recent study highlights the potential of non-viral delivery of CRISPR-Cas9 ribonucleoproteins (RNPs) into the mouse striatum, offering a promising alternative to viral vector-based delivery. Highlights: Non-Viral Delivery of CRISPR-Cas9: The study focuses …

Genetics & Early Language Development: Vocabulary, Literacy, Cognition, ADHD (2023 Study)

by GLOOM

Recent advancements in genetics have illuminated the complex interplay between genetic factors and early vocabulary development in children. A comprehensive meta-genome-wide association study (meta-GWAS) delves into how genetic variations influence the acquisition of vocabulary in infancy and toddlerhood. This research not only enhances our understanding of language development but also sheds light on its genetic …

Genetic (Polygenic) Risk for Psychiatric Disorders & Subject-Specific School Grades (2023 Study)

by GLOOM

The intricate connection between mental health and educational attainment is a subject of growing interest and importance. Recent studies have shed light on how genetic predispositions to certain mental disorders can influence academic performance, challenging our understanding of how mental health impacts learning. Highlights: Polygenic Risk Scores Reveal New Insights: Studies utilizing polygenic risk scores …

Serotonin Transporter Genes (5-HTT) vs. Anxiety / Stress Behaviors & Neuroplasticity in Rats (2024 Study)

by GLOOM

In the intricate world of neuropsychiatric research, the role of serotonin in stress-related behaviors and disorders has long been a topic of fascination. Recent studies on rats have shed new light on this area, revealing intriguing ways in which genetics influence anxiety, depression, and neuroplasticity. Highlights: Serotonin Transporter Genes Influence Stress Behaviors: Rats with modified …